A more recent study evaluated this concept further and found that reduced ADAMTS13 activity and higher VWF antigen levels are associated with metastatic disease and reduced event-free survival, independent of age, gender, and stage-independent predictors of mortality in colorectal cancer [142]. Here, ADAMTS13 is linked to metastatic neoplasm.